TRMED - Executive Management Share Purchase

12 Jun 2026 16:21 CEST

12.6.2026 16:20:57 CEST | Thor Medical ASA | Mandatory notification of trade
primary insiders

Oslo, Norway, 12 June 2026 - Thor Medical ASA announces that Mathias Nilsen
Reierth, Head of Communications & Corporate Affairs and a primary insider of the
company, has purchased 27,777 shares in the company at an average price of NOK
4.14 per share.



Notification of the transaction in accordance with the Market Abuse Regulation
Article 19 is attached to this announcement.



For further information please contact:

Brede Ellingsæter

Chief Financial Officer

Tel: +47 472 38 440

Email: brede.ellingseter@thormedical.no



Mathias Nilsen Reierth

Head of Communications and Corporate Affairs

Tel: +47 988 05 724

Email: mathias.reierth@thormedical.com



ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of alpha particle emitters produced from
naturally occurring thorium, a key component of next-generation targeted cancer
treatment. Its proprietary production process requires no irradiation or use of
nuclear reactors, and provides a reliable, environmentally friendly and
cost-efficient supply of alpha emitters to the radiopharmaceutical industry.
Guided by its vision to become a world-leading enabler for targeted cancer
therapies, Thor Medical is committed to improving millions of lives by fueling
next-generation cancer therapies with high-purity isotopes. Thor Medical is
headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange under the
ticker symbol TRMED. For more information, visit www.thormedical.com -
http://www.thormedical.com. - http://www.thormedical.com



This information is subject to the disclosure requirements pursuant to the
Market Abuse Regulation article 19 and section 5-12 of the Securities Trading
Act.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18949385/11883/Download%20announc
ement%20as%20PDF.pdf

20260612 - TRMED - PDMR notification MAR_PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18949385/11882/20260612%20-%20TRM
ED%20-%20PDMR%20notification%20MAR_PDF.pdf

More information:
Access the news on Oslo Bors NewsWeb site

676097_Download announcement as PDF.pdf
676097_20260612 - TRMED - PDMR notification MAR_PDF.pdf